These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26776116)

  • 1. First description of SHV-148 mediated extended-spectrum cephalosporin resistance among clinical isolates of Escherichia coli from India.
    Maurya AP; Das Talukdar A; Chanda DD; Chakravarty A; Bhattacharjee A
    Indian J Med Microbiol; 2016; 34(1):33-7. PubMed ID: 26776116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK.
    Doumith M; Dhanji H; Ellington MJ; Hawkey P; Woodford N
    J Antimicrob Chemother; 2012 Apr; 67(4):878-85. PubMed ID: 22210753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli.
    Maurya AP; Choudhury D; Talukdar AD; Dhar Chanda D; Chakravarty A; Bhattacharjee A
    Indian J Med Res; 2015 Jun; 141(6):816-22. PubMed ID: 26205025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of blaSHV-12-carrying Escherichia coli clones and plasmids from human, animal and food sources.
    Alonso CA; Michael GB; Li J; Somalo S; Simón C; Wang Y; Kaspar H; Kadlec K; Torres C; Schwarz S
    J Antimicrob Chemother; 2017 Jun; 72(6):1589-1596. PubMed ID: 28333184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class 1 integrons contributes to antibiotic resistance among clinical isolates of Escherichia coli producing extended-spectrum beta-lactamases.
    Chen T; Feng Y; Yuan JL; Qi Y; Cao YX; Wu Y
    Indian J Med Microbiol; 2013; 31(4):385-9. PubMed ID: 24064647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of IS26-composite transposons and multidrug resistance in conjugative plasmids from Enterobacter cloacae.
    Chen CM; Yu WL; Huang M; Liu JJ; Chen IC; Chen HF; Wu LT
    Microbiol Immunol; 2015 Sep; 59(9):516-25. PubMed ID: 26223152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gilthead seabream (Sparus aurata) as carriers of SHV-12 and TEM-52 extended-spectrum beta-lactamases-containing Escherichia coli isolates.
    Sousa M; Torres C; Barros J; Somalo S; Igrejas G; Poeta P
    Foodborne Pathog Dis; 2011 Oct; 8(10):1139-41. PubMed ID: 21657938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and clinical significance of New Delhi metallo-beta-lactamases-1 producing Escherichia coli recovered from a South Indian tertiary care hospital.
    Ckakraborty A; Adhikari P; Shenoy S; Baliga S; Bhat G; Rao S; Biranthabail D; Saralaya V
    Indian J Pathol Microbiol; 2015; 58(3):323-7. PubMed ID: 26275254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel.
    Sompolinsky D; Nitzan Y; Tetry S; Wolk M; Vulikh I; Kerrn MB; Sandvang D; Hershkovits G; Katcoff DJ
    J Antimicrob Chemother; 2005 Jan; 55(1):119-22. PubMed ID: 15574469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT; van Duijkeren E; Fluit AC; Gaastra W
    Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain.
    Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli.
    Sidjabat HE; Seah KY; Coleman L; Sartor A; Derrington P; Heney C; Faoagali J; Nimmo GR; Paterson DL
    Int J Antimicrob Agents; 2014 Sep; 44(3):203-8. PubMed ID: 25052868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.
    Dhanji H; Doumith M; Rooney PJ; O'Leary MC; Loughrey AC; Hope R; Woodford N; Livermore DM
    J Antimicrob Chemother; 2011 Feb; 66(2):297-303. PubMed ID: 21131323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IncX3 plasmid mediated occurrence of bla
    Choudhury NA; Paul D; Chakravarty A; Bhattacharjee A; Dhar Chanda D
    J Infect Public Health; 2018; 11(1):111-114. PubMed ID: 28676284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.